Trial NCT03790111

View at ClinicalTrials.gov 
Org. Study IDs: LX1606.1-207-BTC
Secondary IDs: LX1606.207

Last trial update was posted on 2023-04-19

MeSH Interventions

Cisplatin Gemcitabine

MeSH Conditions

Biliary Tract Neoplasms

Other Conditions

Biliary Tract Cancer (BTC)

Stopping Reasons

Did not meet pre-specified Progression-Free Survival at Month 6 for Stage 2 Analysis

Limitations And Caveats

This study was halted prematurely as it did not meet pre-specified Progression-Free Survival at Month 6 for Stage 2 Analysis. Due to early discontinuation of the study with limited data, the study results (data) at Month 12 and End of Study may be unreliable and uninterpretable.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID